RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment

RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment

RotaChrom Technologies, the developer of the world's first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab''), a cyclodextrin research, development and manufacturing company. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.

 

GlobeNewswire